4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000232
EVP, Chief Business Officer sold 11,950 shares at $62.16 ($742,838)
- EVP, Chief Business Officer acquired 11,950 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baroldi Joseph EVP, Chief Business Officer | 2025-09-09 | Option exercise 10b5-1 | +11,950 | $31.80 | $380,010 | 43,876 | D |
| Baroldi Joseph EVP, Chief Business Officer | 2025-09-09 | Sale 10b5-1 | −11,950 | $62.16 | $742,838 | 31,926 | D |
| Derivatives | |||||||
| Baroldi Joseph EVP, Chief Business Officer | 2025-09-09 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −11,950 | 41,700 | D | ||
| Open-market sales · 11,950 sh · avg $62.16 · $742,838 | |||||||
Loading xslF345X05/edgardoc.xml…